Olmesartan therapy and enteropathy: About two cases and review of the literature

La Revue de médecine interne
A SadkiI Marie

Abstract

Olmesartan is an angiotensin II receptor blocker, used to treat arterial hypertension. Severe digestive manifestations have been associated with olmesartan, including sprue-like enteropathy and lymphocytic colitis. We report two cases of sprue-like enteropathy associated with olmesartan, leading to malabsorption syndrome related to villous atrophy. After olmesartan discontinuation, patients exhibited resolution of clinical digestive symptoms and disappearance of biochemical abnormalities. Our case reports underscore that accurate questioning is crucial in diagnostic approach, allowing to make the diagnosis of sprue-like enteropathy related to olmesartan in our patients. Interestingly, particular attention has recently been drawn to the fact that sprue-like disease may be a class effect of angiotensin II receptor blockers; further investigations are warranted to confirm these latter data.

References

Nov 1, 1993·Digestive Diseases and Sciences·J HartA D Schwabe
Nov 10, 1998·Transplantation·D DuclouxJ M Chalopin
Jan 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·O ChassanyJ F Bergmann
Aug 16, 2005·Alimentary Pharmacology & Therapeutics·L Beaugerie, D S Pardi
Aug 8, 2007·The American Journal of Gastroenterology·Fernando Fernández-BañaresJosep Maria Viver
Jun 17, 2008·Annales de pathologie·Denis ChatelainJean-François Fléjou
Feb 9, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·H WeclawiakN Kamar
Mar 11, 2011·The New England Journal of Medicine·Hermann HallerUNKNOWN ROADMAP Trial Investigators
Oct 11, 2011·Cardiology in Review·Sum Lam
Mar 16, 2012·Journal of Hypertension·Jan MenneUNKNOWN ROADMAP investigators
Jun 26, 2012·Mayo Clinic Proceedings·Alberto Rubio-TapiaJoseph A Murray
Jul 11, 2012·Biochemical and Biophysical Research Communications·Lihua SunHua Yang
Dec 12, 2012·Mayo Clinic Proceedings·Jan Menne, Hermann Haller
Apr 2, 2013·Mayo Clinic Proceedings·Nicole M GentileJoseph A Murray
May 7, 2013·The American Journal of Gastroenterology·Marisa DeGaetaniPeter H R Green
Jun 12, 2013·Journal of Clinical Gastroenterology·Peter P StanichMarty M Meyer
Dec 18, 2013·Gastroenterology·Varun GaurLuke Weber
Jan 30, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Hélène ThéophileFrançoise Haramburu
May 9, 2014·Alimentary Pharmacology & Therapeutics·G IaniroG Cammarota
Jun 25, 2014·Gastroenterología y hepatología·Sandra Agudo Fernández
Jul 9, 2014·The American Journal of Gastroenterology·Gilles MacaigneStéphane Nahon
Aug 12, 2014·Alimentary Pharmacology & Therapeutics·J CyranyM Kopacova
Aug 12, 2014·Alimentary Pharmacology & Therapeutics·G CammarotaA Gasbarrini
Sep 10, 2014·Alimentary Pharmacology & Therapeutics·L MartheyF Carbonnel
Oct 11, 2014·Alimentary Pharmacology & Therapeutics·B Lebwohl, J F Ludvigsson
Oct 12, 2014·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Naresh BhatKayal Vizhi
Dec 17, 2014·Expert Opinion on Emerging Drugs·Hugh James Freeman
Jan 15, 2015·Internal Medicine Journal·N HeerasingS Wallace
Jun 24, 2015·PloS One·Sophie ScialomChristophe Cellier
Jul 15, 2015·ACG Case Reports Journal·Margot L HermanJoseph A Murray
Sep 29, 2015·Archives of Pathology & Laboratory Medicine·Eun-Young Karen Choi, Barbara J McKenna
Oct 2, 2015·Alimentary Pharmacology & Therapeutics·E V MariettaJ A Murray
May 1, 2016·Annales de cardiologie et d'angéiologie·M Ould Sidi Mohamed, P Colardelle
Jul 26, 2016·Canadian Journal of Gastroenterology & Hepatology·Claudine DesruisseauxThibaut Manière
Dec 17, 2016·Internal Medicine·Takanori UeharaYusuke Hirota
Jul 15, 2017·Alimentary Pharmacology & Therapeutics·M ZanelliL De Marco
Mar 28, 2016·GE Portuguese Journal of Gastroenterology·Isabel A Hujoel, Alberto Rubio-Tapia
Nov 8, 2017·The American Journal of Gastroenterology·T van GilsC J J Mulder
Jan 24, 2018·Alimentary Pharmacology & Therapeutics·Y-H DongJ J Gagne
Apr 8, 2018·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·C MelisK Deraedt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Mayo Clinic Proceedings
Alberto Rubio-TapiaJoseph A Murray
Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology
Michail GalanopoulosGerassimos J Mantzaris
Canadian Journal of Gastroenterology & Hepatology
Tasha KulaiJohn Igoe
Gastroenterología y hepatología
Sandra Agudo Fernández
© 2022 Meta ULC. All rights reserved